- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02288494
Acid Base Balance of ICU Patients With Severe Hypoalbuminemia, Before and After an Albumin Infusion, Using Stewart Approach (STEWALB)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Prospective study, for ICU patient with severe hypoalbuminemia < 20g/L, determining biological parameters from Stewart approach for acid base disorders (pH, SIDe, SIDa, SIG, Atot, PaCO2) before, and at 1hour, 2hours and 24 hours after a 200mL 20% human albumin perfusion (the consensus conference ANAES of 1995 recommands to correct hypoalbuminemia below 20g/L).
Clinical parameters (respiratory, haemodynamic, neurologic) were also collected at the same times.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France, 63003
- CHU de Clermont-Ferrand
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- serum albuminemia < 20g/L
- adult ICU patient
- Arterial line
Exclusion Criteria:
- albumin allergy
- pregnancy
- congestive heart failure
Study Plan
How is the study designed?
Design Details
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
hypoalbuminemia
The primary purpose was to describe the acid base balance of ICU patients with severe hypoalbuminemia using Stewart's approach for acid base disorders, before and after an human albumin perfusion
|
Prospective study, for ICU patient with severe hypoalbuminemia < 20g/L, determining biological parameters from Stewart approach for acid base disorders (pH, SIDe, SIDa, SIG, Atot, PaCO2) before, and at 1hour, 2hours and 24 hours after a 200mL 20% human al Clinical parameters (respiratory, haemodynamic, neurologic) were also collected at the same times.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
changes in pH and independent pH determinants using Stewart approach
Time Frame: at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion.
|
at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
changes in neurologic parameters
Time Frame: at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion.
|
at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion.
|
changes in hemodynamic parameters
Time Frame: at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion.
|
at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion.
|
changes in respiratory parameters
Time Frame: at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion.
|
at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Julien PASCAL, University Hospital, Clermont-Ferrand
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHU-0204
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypoalbuminemia
-
Technical University of MunichCompleted
-
Akron Children's HospitalCompletedHypoalbuminemiaUnited States
-
University of Colorado, DenverCompletedHyperphosphatemia | Hypoalbuminemia | Peritoneal Dialysis ComplicationUnited States
-
Centre hospitalier de l'Université de Montréal...Centre de Recherche du Centre Hospitalier de l'Université de MontréalWithdrawn
-
University of Texas Southwestern Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...TerminatedHepatic Insufficiency | HypoalbuminemiaUnited States
-
Hospital San Juan de la CruzCompleted
-
George A. Kaysen, M.D.Beth Israel Medical CenterTerminatedHypoalbuminemiaUnited States
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenUnknownCritically Ill PatientsBelgium
-
Healthgen Biotechnology Corp.CompletedHypoalbuminemia | Hepatic CirrhosisChina
-
Kaiser PermanenteCompletedMalnutrition | Hypoalbuminemia | Peritoneal Dialysis ComplicationUnited States
Clinical Trials on stewart approach
-
Sahlgrenska University Hospital, SwedenVastra Gotaland RegionRecruitingMuscle Weakness | Muscle Atrophy | Hip Osteoarthritis | Arthroplasty Complications | Muscle InjurySweden
-
University of Sao Paulo General HospitalUniversity of Campinas, BrazilUnknown
-
Iuliu Hatieganu University of Medicine and PharmacyEmergency County Hospital Cluj-NapocaCompleted
-
Florida Orthopaedic InstituteOrthopaedic Trauma AssociationCompletedTibial FracturesUnited States
-
Sorlandet Hospital HFUnknown
-
Fraser Orthopaedic Research SocietyCompletedINfrapatellar Versus SUprapatellar Reamed Intramedullary Nailing for Fractures of the Tibia (INSURT)Tibial Fractures | Anterior Knee Pain SyndromeCanada, Spain
-
Cairo UniversityCompletedFacial Nerve Injuries | Subcondylar Process of Mandible Open FractureEgypt
-
Assiut UniversityUnknown
-
University Hospital, Clermont-FerrandUnknown
-
Medacta USAMedacta International SACompletedOsteoarthritisUnited States